169 related articles for article (PubMed ID: 21271647)
1. Back to the future: proceedings from the 2010 NF Conference.
Huson SM; Acosta MT; Belzberg AJ; Bernards A; Chernoff J; Cichowski K; Gareth Evans D; Ferner RE; Giovannini M; Korf BR; Listernick R; North KN; Packer RJ; Parada LF; Peltonen J; Ramesh V; Reilly KM; Risner JW; Schorry EK; Upadhyaya M; Viskochil DH; Zhu Y; Hunter-Schaedle K; Giancotti FG
Am J Med Genet A; 2011 Feb; 155A(2):307-21. PubMed ID: 21271647
[TBL] [Abstract][Full Text] [Related]
2. CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies.
Widemann BC; Acosta MT; Ammoun S; Belzberg AJ; Bernards A; Blakeley J; Bretscher A; Cichowski K; Clapp DW; Dombi E; Evans GD; Ferner R; Fernandez-Valle C; Fisher MJ; Giovannini M; Gutmann DH; Hanemann CO; Hennigan R; Huson S; Ingram D; Kissil J; Korf BR; Legius E; Packer RJ; McClatchey AI; McCormick F; North K; Pehrsson M; Plotkin SR; Ramesh V; Ratner N; Schirmer S; Sherman L; Schorry E; Stevenson D; Stewart DR; Ullrich N; Bakker AC; Morrison H
Am J Med Genet A; 2014 Mar; 164A(3):563-78. PubMed ID: 24443315
[TBL] [Abstract][Full Text] [Related]
3. From process to progress-2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis.
Ferner RE; Bakker A; Elgersma Y; Evans DGR; Giovannini M; Legius E; Lloyd A; Messiaen LM; Plotkin S; Reilly KM; Schindeler A; Smith MJ; Ullrich NJ; Widemann B; Sherman LS
Am J Med Genet A; 2019 Jun; 179(6):1098-1106. PubMed ID: 30908866
[TBL] [Abstract][Full Text] [Related]
4. First International Conference on RASopathies and Neurofibromatoses in Asia: Identification and advances of new therapeutics.
Rauen KA; Alsaegh A; Ben-Shachar S; Berman Y; Blakeley J; Cordeiro I; Elgersma Y; Evans DG; Fisher MJ; Frayling IM; George J; Huson SM; Kerr B; Khire U; Korf B; Legius E; Messiaen L; van Minkelen R; Nampoothiri S; Ngeow J; Parada LF; Phadke S; Pillai A; Plotkin SR; Puri R; Raji A; Ramesh V; Ratner N; Shankar SP; Sharda S; Tambe A; Vikkula M; Widemann BC; Wolkenstein P; Upadhyaya M
Am J Med Genet A; 2019 Jun; 179(6):1091-1097. PubMed ID: 30908877
[TBL] [Abstract][Full Text] [Related]
5. Neurofibromatosis as a gateway to better treatment for a variety of malignancies.
Bakker AC; La Rosa S; Sherman LS; Knight P; Lee H; Pancza P; Nievo M
Prog Neurobiol; 2017 May; 152():149-165. PubMed ID: 26854064
[TBL] [Abstract][Full Text] [Related]
6. Establishing priorities in neurofibromatosis research: a workshop summary.
MacCollin M; Gutmann DH; Korf B; Finkelstein R
Genet Med; 2001; 3(3):212-7. PubMed ID: 11388764
[TBL] [Abstract][Full Text] [Related]
7. Achieving consensus for clinical trials: the REiNS International Collaboration.
Plotkin SR; Blakeley JO; Dombi E; Fisher MJ; Hanemann CO; Walsh KS; Wolters PL; Widemann BC
Neurology; 2013 Nov; 81(21 Suppl 1):S1-5. PubMed ID: 24249801
[TBL] [Abstract][Full Text] [Related]
8. Neurofibromatosis.
Korf BR
Handb Clin Neurol; 2013; 111():333-40. PubMed ID: 23622184
[TBL] [Abstract][Full Text] [Related]
9. Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 2 and Related Disorders.
Evans DGR; Salvador H; Chang VY; Erez A; Voss SD; Druker H; Scott HS; Tabori U
Clin Cancer Res; 2017 Jun; 23(12):e54-e61. PubMed ID: 28620005
[TBL] [Abstract][Full Text] [Related]
10. What's new in neurofibromatosis? Proceedings from the 2009 NF Conference: new frontiers.
Kissil JL; Blakeley JO; Ferner RE; Huson SM; Kalamarides M; Mautner VF; McCormick F; Morrison H; Packer R; Ramesh V; Ratner N; Rauen KA; Stevenson DA; Hunter-Schaedle K; North K
Am J Med Genet A; 2010 Feb; 152A(2):269-83. PubMed ID: 20082461
[TBL] [Abstract][Full Text] [Related]
11. Nosological considerations of the neurofibromatoses.
Viskochil D; Carey JC
J Dermatol; 1992 Nov; 19(11):873-80. PubMed ID: 1293176
[TBL] [Abstract][Full Text] [Related]
12. Recent developments in neurofibromatoses and RASopathies: management, diagnosis and current and future therapeutic avenues.
Rauen KA; Huson SM; Burkitt-Wright E; Evans DG; Farschtschi S; Ferner RE; Gutmann DH; Hanemann CO; Kerr B; Legius E; Parada LF; Patton M; Peltonen J; Ratner N; Riccardi VM; van der Vaart T; Vikkula M; Viskochil DH; Zenker M; Upadhyaya M
Am J Med Genet A; 2015 Jan; 167A(1):1-10. PubMed ID: 25393061
[TBL] [Abstract][Full Text] [Related]
13. Neurofibromatosis. Nosological considerations.
Badiu C; Stefanache F
Rev Med Chir Soc Med Nat Iasi; 2000; 104(2):39-44. PubMed ID: 12089989
[TBL] [Abstract][Full Text] [Related]
14. Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis.
Tamura R
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072574
[TBL] [Abstract][Full Text] [Related]
15. Lessons learned from drug trials in neurofibromatosis: A systematic review.
Dhaenens BAE; Ferner RE; Evans DG; Heimann G; Potratz C; van de Ketterij E; Kaindl AM; Hissink G; Carton C; Bakker A; Nievo M; Legius E; Oostenbrink R
Eur J Med Genet; 2021 Sep; 64(9):104281. PubMed ID: 34237445
[TBL] [Abstract][Full Text] [Related]
16. Neurofibromatoses: part 1 - diagnosis and differential diagnosis.
Rodrigues LO; Batista PB; Goloni-Bertollo EM; de Souza-Costa D; Eliam L; Eliam M; Cunha KS; Darrigo-Junior LG; Ferraz-Filho JR; Geller M; Gianordoli-Nascimento IF; Madeira LG; Malloy-Diniz LF; Mendes HM; de Miranda DM; Pavarino EC; Baptista-Pereira L; Rezende NA; Rodrigues Lde O; da Silva CM; de Souza JF; de Souza ML; Stangherlin A; Valadares ER; Vidigal PV
Arq Neuropsiquiatr; 2014 Mar; 72(3):241-50. PubMed ID: 24676443
[TBL] [Abstract][Full Text] [Related]
17. [Neurofibromatosis--an inborn genetic disorder with susceptibility to neoplasia].
Karwacki MW; Woźniak W
Med Wieku Rozwoj; 2006; 10(3 Pt 2):923-48. PubMed ID: 17401183
[TBL] [Abstract][Full Text] [Related]
18. Clinical features of spinal schwannomas in 65 patients with schwannomatosis compared with 831 with solitary schwannomas and 102 with neurofibromatosis Type 2: a retrospective study at a single institution.
Li P; Zhao F; Zhang J; Wang Z; Wang X; Wang B; Yang Z; Yang J; Gao Z; Liu P
J Neurosurg Spine; 2016 Jan; 24(1):145-54. PubMed ID: 26407091
[TBL] [Abstract][Full Text] [Related]
19. Genomic Profiling in Patients With Malignant Peripheral Nerve Sheath Tumors Reveals Multiple Pathways With Targetable Mutations.
Kaplan HG; Rostad S; Ross JS; Ali SM; Millis SZ
J Natl Compr Canc Netw; 2018 Aug; 16(8):967-974. PubMed ID: 30099373
[No Abstract] [Full Text] [Related]
20. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
Gottfried ON; Viskochil DH; Couldwell WT
Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
